Obesity is quickly becoming a worldwide epidemic, and there are currently no effective therapies. Despite their promise, early treatment strategies failed to demonstrate clinical efficacy, which has prompted researchers to focus on the development of combinatorial therapies. Some of the earlier strategies relied on stimulation of β3-adrenergic receptors, and there is recent evidence that the effect of β3-adrenergic activation could be potentiated by combining it with PPARβ-receptor activation. To explore this possibility in vivo, Fernando Rodríguez de Fonseca and colleagues subjected rats to co-treatment with a β3-adrenergic agonist and a PPARβ-activating ligand. This had an effect on multiple processes involved in energy balance, including feeding, thermogenesis and fatty acid oxidation, promoting an overall increase in energy expenditure and decrease in energy intake. These results suggest that pharmacological combination of PPARβ and β3-adrenergic receptor agonists could represent a promising therapy for treating obesity. Page 129
A combinatorial therapy for treating obesity
- Split-screen
- Views Icon Views
-
Article Versions Icon
Versions
- Version of Record 01 January 2014
- Share Icon Share
-
Tools Icon
Tools
- Search Site
A combinatorial therapy for treating obesity. Dis Model Mech 1 January 2014; 7 (1): 1. doi:
Download citation file:
Advertisement
Cited by
Special Issue: The RAS Pathway

Our latest special issue is now complete. It showcases RAS-driven mechanisms of disease progression, and highlights approaches to treat and modify the disease course in model systems.
Call for papers: Moving Heart Failure to Heart Success

Disease Models & Mechanisms is pleased to welcome submissions for consideration for an upcoming special issue, Moving Heart Failure to Heart Success: Mechanisms, Regeneration & Therapy. The deadline for submitting articles to the special issue has been extended to 1 August 2022.
Propose a new Workshop

Our Workshops bring together leading experts and early-career researchers from a range of scientific backgrounds. Applications are now open to propose Workshops for 2024, one of which will be held in a Global South country. .
A focus on Drosophila

In a series of front section articles, DMM is highlighting the versatility, breadth, and scope of Drosophila research in human disease modelling and translational medicine.
Apply for a DMM Conference Travel Grant

Aimed at early-career researchers wanting to attend in-person and virtual meetings, the next application deadline for a DMM Conference Travel Grant is 6 June 2022. Find out more and hear from past recipients about their experience of the grant.
Other journals from
The Company of Biologists